Academic Journal
Προβολή σε EDS
Συνδεδεμένο Πλήρες Κείμενο

Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices.
Συγγραφείς: Meredith LR; From the Department of Psychology, University of California, Los Angeles, Los Angeles, CA (LRM, LAR); Los Angeles County Department of Public Health, Los Angeles, CA (BH); Friends Research Institute, Cerritos, CA (BH, TCF, LR, BL, NM, TD); Los Angeles County Department of Health Services, Los Angeles, CA (TCF, HKB, SH); Department of Internal Medicine, Charles R. Drew University, Los Angeles, CA (TCF, MLL); Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA (MLL); Brain Research Institute, University of California, Los Angeles, Los Angeles, CA (LAR); and Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA (LAR)., Hurley B, Friedman TC, Lee ML, Rodriguez L, Lopez B, Mtume N, Dixon T, Belani HK, Hsieh S, Ray LA
Πηγή: Journal of addiction medicine [J Addict Med] 2023 Nov-Dec 01; Vol. 17 (6), pp. 677-684. Date of Electronic Publication: 2023 Aug 18.
Τύπος έκδοσης: Randomized Controlled Trial; Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 101306759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-3227 (Electronic) Linking ISSN: 19320620 NLM ISO Abbreviation: J Addict Med Subsets: MEDLINE
Imprint Name(s): Publication: [Alphen aan den Rijn, the Netherlands] : Wolters Kluwer Health, Inc.
Original Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Ιατρικοί όροι (MeSH): Tobacco Use Disorder* , Smoking Cessation*, Adult ; Humans ; Public Health ; Nicotine ; Tobacco Use
Περίληψη: Objectives: Although public efforts to reduce tobacco use have been successful, millions of US adults currently smoke tobacco. Reducing the public health burden of tobacco use disorder (TUD) and eliminating disparities experienced by underresourced communities requires increased accessibility to services. The goal of this study was to assess whether prescriptions for evidence-based medications for tobacco treatment showed steeper growth rates among community health clinics providing specialty TUD services as compared with treatment as usual.
Methods: Clinic-wide data on prescriptions for smoking cessation pharmacotherapy at 18 primary care or mental health community clinics operated by Los Angeles County were retrieved for 4 years of an ongoing implementation trial. Specialty services included behavioral counseling and medications for tobacco treatment. Descriptive statistics characterized prescriptions rates across clinics and time. Analyses compared the slopes of the changes between intervention groups across time for primary care and mental health sites.
Results: Within primary care clinics, the most commonly prescribed smoking cessation medications were nicotine patches, nicotine gum, and varenicline. Throughout the trial, all clinics displayed increased rates of prescribing smoking cessation medications. Analytic results supported overall steeper increases in prescription rates for these medications among clinics randomized to specialty services versus treatment as usual within primary care ( P = 0.020) and mental health sites ( P = 0.004).
Conclusions: This work provides support for the effectiveness of community-based implementation interventions that promote prescribing smoking cessation medications with the potential to reduce health disparities among communities at greater risk for TUD and its consequences.
(Copyright © 2023 American Society of Addiction Medicine.)
Competing Interests: The authors report no conflicts of interest.
References: Front Psychiatry. 2021 Sep 28;12:744816. (PMID: 34650457)
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59. (PMID: 29346338)
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019. (PMID: 31725711)
N Engl J Med. 2010 Jun 17;362(24):2295-303. (PMID: 20554984)
Addict Behav. 2022 Aug;131:107329. (PMID: 35397262)
Front Pharmacol. 2022 Oct 24;13:1012433. (PMID: 36353488)
Nicotine Tob Res. 2023 Jan 5;25(2):345-349. (PMID: 35778237)
Cochrane Database Syst Rev. 2012 May 16;(5):CD000214. (PMID: 22592671)
JAMA. 2022 Feb 08;327(6):566-577. (PMID: 35133411)
J Rural Health. 2017 Apr;33(2):180-189. (PMID: 27074968)
Lancet. 2006 Jul 29;368(9533):367-70. (PMID: 16876664)
Int J Clin Pract. 2021 Nov;75(11):e14594. (PMID: 34228852)
Nicotine Tob Res. 2015 Dec;17(12):1405-15. (PMID: 25744958)
Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):87-91. (PMID: 29524601)
JAMA. 2021 Jan 19;325(3):280-298. (PMID: 33464342)
Am J Drug Alcohol Abuse. 2017 Jul;43(4):416-431. (PMID: 27286288)
Exp Clin Psychopharmacol. 2023 Apr;31(2):541-559. (PMID: 35771496)
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221107984. (PMID: 35748431)
Med Clin North Am. 2022 Jan;106(1):99-112. (PMID: 34823737)
High Blood Press Cardiovasc Prev. 2020 Oct;27(5):349-362. (PMID: 32578165)
Behav Med. 2007 Winter;32(4):135-49. (PMID: 17348429)
JAMA Netw Open. 2023 Feb 1;6(2):e2254655. (PMID: 36745457)
Nicotine Tob Res. 2008 Dec;10(12):1691-715. (PMID: 19023823)
Implement Sci. 2019 Jan 5;14(1):1. (PMID: 30611302)
Curr Psychiatry Rep. 2012 Oct;14(5):478-85. (PMID: 22821177)
J Psychiatr Ment Health Nurs. 2018 May;25(4):270-282. (PMID: 29498459)
CA Cancer J Clin. 2018 Mar;68(2):106-115. (PMID: 29384589)
Cochrane Database Syst Rev. 2019 Jun 05;6:CD009670. (PMID: 31166007)
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464. (PMID: 28056007)
Int J Environ Res Public Health. 2017 Sep 28;14(10):. (PMID: 28956852)
Trials. 2022 Feb 3;23(1):109. (PMID: 35115017)
Implement Sci. 2015 Feb 12;10:21. (PMID: 25889199)
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742. (PMID: 33211681)
Grant Information: F31 AA029295 United States AA NIAAA NIH HHS
Molecular Sequence: ClinicalTrials.gov NCT04717544
Substance Nomenclature: 6M3C89ZY6R (Nicotine)
Entry Date(s): Date Created: 20231107 Date Completed: 20231108 Latest Revision: 20250225
Update Code: 20260130
PubMed Central ID: PMC11849139
DOI: 10.1097/ADM.0000000000001211
PMID: 37934530
Βάση Δεδομένων: MEDLINE
FullText Links:
  – Type: other
    Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=42AAAB84E9AD88DF6EA7&Show=Object
Text:
  Availability: 0
Header DbId: cmedm
DbLabel: MEDLINE
An: 37934530
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Meredith+LR%22">Meredith LR</searchLink>; From the Department of Psychology, University of California, Los Angeles, Los Angeles, CA (LRM, LAR); Los Angeles County Department of Public Health, Los Angeles, CA (BH); Friends Research Institute, Cerritos, CA (BH, TCF, LR, BL, NM, TD); Los Angeles County Department of Health Services, Los Angeles, CA (TCF, HKB, SH); Department of Internal Medicine, Charles R. Drew University, Los Angeles, CA (TCF, MLL); Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA (MLL); Brain Research Institute, University of California, Los Angeles, Los Angeles, CA (LAR); and Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA (LAR).<br /><searchLink fieldCode="AU" term="%22Hurley+B%22">Hurley B</searchLink><br /><searchLink fieldCode="AU" term="%22Friedman+TC%22">Friedman TC</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+ML%22">Lee ML</searchLink><br /><searchLink fieldCode="AU" term="%22Rodriguez+L%22">Rodriguez L</searchLink><br /><searchLink fieldCode="AU" term="%22Lopez+B%22">Lopez B</searchLink><br /><searchLink fieldCode="AU" term="%22Mtume+N%22">Mtume N</searchLink><br /><searchLink fieldCode="AU" term="%22Dixon+T%22">Dixon T</searchLink><br /><searchLink fieldCode="AU" term="%22Belani+HK%22">Belani HK</searchLink><br /><searchLink fieldCode="AU" term="%22Hsieh+S%22">Hsieh S</searchLink><br /><searchLink fieldCode="AU" term="%22Ray+LA%22">Ray LA</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101306759%22">Journal of addiction medicine</searchLink> [J Addict Med] 2023 Nov-Dec 01; Vol. 17 (6), pp. 677-684. <i>Date of Electronic Publication: </i>2023 Aug 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101306759 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-3227 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219320620%22">19320620 </searchLink><i>NLM ISO Abbreviation: </i>J Addict Med <i>Subsets: </i>MEDLINE
– Name: PublisherInfo
  Label: Imprint Name(s)
  Group: PubInfo
  Data: <i>Publication</i>: [Alphen aan den Rijn, the Netherlands] : Wolters Kluwer Health, Inc.<br /><i>Original Publication</i>: Hagerstown, MD : Lippincott Williams & Wilkins
– Name: SubjectMESH
  Label: MeSH Terms
  Group: Su
  Data: <searchLink fieldCode="MM" term="%22Tobacco+Use+Disorder%22">Tobacco Use Disorder*</searchLink> <br /><searchLink fieldCode="MM" term="%22Smoking+Cessation%22">Smoking Cessation*</searchLink><br /><searchLink fieldCode="MH" term="%22Adult%22">Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Public+Health%22">Public Health</searchLink> ; <searchLink fieldCode="MH" term="%22Nicotine%22">Nicotine</searchLink> ; <searchLink fieldCode="MH" term="%22Tobacco+Use%22">Tobacco Use</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objectives: Although public efforts to reduce tobacco use have been successful, millions of US adults currently smoke tobacco. Reducing the public health burden of tobacco use disorder (TUD) and eliminating disparities experienced by underresourced communities requires increased accessibility to services. The goal of this study was to assess whether prescriptions for evidence-based medications for tobacco treatment showed steeper growth rates among community health clinics providing specialty TUD services as compared with treatment as usual.<br />Methods: Clinic-wide data on prescriptions for smoking cessation pharmacotherapy at 18 primary care or mental health community clinics operated by Los Angeles County were retrieved for 4 years of an ongoing implementation trial. Specialty services included behavioral counseling and medications for tobacco treatment. Descriptive statistics characterized prescriptions rates across clinics and time. Analyses compared the slopes of the changes between intervention groups across time for primary care and mental health sites.<br />Results: Within primary care clinics, the most commonly prescribed smoking cessation medications were nicotine patches, nicotine gum, and varenicline. Throughout the trial, all clinics displayed increased rates of prescribing smoking cessation medications. Analytic results supported overall steeper increases in prescription rates for these medications among clinics randomized to specialty services versus treatment as usual within primary care ( P = 0.020) and mental health sites ( P = 0.004).<br />Conclusions: This work provides support for the effectiveness of community-based implementation interventions that promote prescribing smoking cessation medications with the potential to reduce health disparities among communities at greater risk for TUD and its consequences.<br /> (Copyright © 2023 American Society of Addiction Medicine.)
– Name: Abstract
  Label: Competing Interests
  Group: Ab
  Data: The authors report no conflicts of interest.
– Name: Ref
  Label: References
  Group: RefInfo
  Data: Front Psychiatry. 2021 Sep 28;12:744816. (PMID: <searchLink fieldCode="PM" term="%2234650457%22">34650457)</searchLink><br />MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59. (PMID: <searchLink fieldCode="PM" term="%2229346338%22">29346338)</searchLink><br />MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019. (PMID: <searchLink fieldCode="PM" term="%2231725711%22">31725711)</searchLink><br />N Engl J Med. 2010 Jun 17;362(24):2295-303. (PMID: <searchLink fieldCode="PM" term="%2220554984%22">20554984)</searchLink><br />Addict Behav. 2022 Aug;131:107329. (PMID: <searchLink fieldCode="PM" term="%2235397262%22">35397262)</searchLink><br />Front Pharmacol. 2022 Oct 24;13:1012433. (PMID: <searchLink fieldCode="PM" term="%2236353488%22">36353488)</searchLink><br />Nicotine Tob Res. 2023 Jan 5;25(2):345-349. (PMID: <searchLink fieldCode="PM" term="%2235778237%22">35778237)</searchLink><br />Cochrane Database Syst Rev. 2012 May 16;(5):CD000214. (PMID: <searchLink fieldCode="PM" term="%2222592671%22">22592671)</searchLink><br />JAMA. 2022 Feb 08;327(6):566-577. (PMID: <searchLink fieldCode="PM" term="%2235133411%22">35133411)</searchLink><br />J Rural Health. 2017 Apr;33(2):180-189. (PMID: <searchLink fieldCode="PM" term="%2227074968%22">27074968)</searchLink><br />Lancet. 2006 Jul 29;368(9533):367-70. (PMID: <searchLink fieldCode="PM" term="%2216876664%22">16876664)</searchLink><br />Int J Clin Pract. 2021 Nov;75(11):e14594. (PMID: <searchLink fieldCode="PM" term="%2234228852%22">34228852)</searchLink><br />Nicotine Tob Res. 2015 Dec;17(12):1405-15. (PMID: <searchLink fieldCode="PM" term="%2225744958%22">25744958)</searchLink><br />Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):87-91. (PMID: <searchLink fieldCode="PM" term="%2229524601%22">29524601)</searchLink><br />JAMA. 2021 Jan 19;325(3):280-298. (PMID: <searchLink fieldCode="PM" term="%2233464342%22">33464342)</searchLink><br />Am J Drug Alcohol Abuse. 2017 Jul;43(4):416-431. (PMID: <searchLink fieldCode="PM" term="%2227286288%22">27286288)</searchLink><br />Exp Clin Psychopharmacol. 2023 Apr;31(2):541-559. (PMID: <searchLink fieldCode="PM" term="%2235771496%22">35771496)</searchLink><br />J Prim Care Community Health. 2022 Jan-Dec;13:21501319221107984. (PMID: <searchLink fieldCode="PM" term="%2235748431%22">35748431)</searchLink><br />Med Clin North Am. 2022 Jan;106(1):99-112. (PMID: <searchLink fieldCode="PM" term="%2234823737%22">34823737)</searchLink><br />High Blood Press Cardiovasc Prev. 2020 Oct;27(5):349-362. (PMID: <searchLink fieldCode="PM" term="%2232578165%22">32578165)</searchLink><br />Behav Med. 2007 Winter;32(4):135-49. (PMID: <searchLink fieldCode="PM" term="%2217348429%22">17348429)</searchLink><br />JAMA Netw Open. 2023 Feb 1;6(2):e2254655. (PMID: <searchLink fieldCode="PM" term="%2236745457%22">36745457)</searchLink><br />Nicotine Tob Res. 2008 Dec;10(12):1691-715. (PMID: <searchLink fieldCode="PM" term="%2219023823%22">19023823)</searchLink><br />Implement Sci. 2019 Jan 5;14(1):1. (PMID: <searchLink fieldCode="PM" term="%2230611302%22">30611302)</searchLink><br />Curr Psychiatry Rep. 2012 Oct;14(5):478-85. (PMID: <searchLink fieldCode="PM" term="%2222821177%22">22821177)</searchLink><br />J Psychiatr Ment Health Nurs. 2018 May;25(4):270-282. (PMID: <searchLink fieldCode="PM" term="%2229498459%22">29498459)</searchLink><br />CA Cancer J Clin. 2018 Mar;68(2):106-115. (PMID: <searchLink fieldCode="PM" term="%2229384589%22">29384589)</searchLink><br />Cochrane Database Syst Rev. 2019 Jun 05;6:CD009670. (PMID: <searchLink fieldCode="PM" term="%2231166007%22">31166007)</searchLink><br />MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464. (PMID: <searchLink fieldCode="PM" term="%2228056007%22">28056007)</searchLink><br />Int J Environ Res Public Health. 2017 Sep 28;14(10):. (PMID: <searchLink fieldCode="PM" term="%2228956852%22">28956852)</searchLink><br />Trials. 2022 Feb 3;23(1):109. (PMID: <searchLink fieldCode="PM" term="%2235115017%22">35115017)</searchLink><br />Implement Sci. 2015 Feb 12;10:21. (PMID: <searchLink fieldCode="PM" term="%2225889199%22">25889199)</searchLink><br />MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742. (PMID: <searchLink fieldCode="PM" term="%2233211681%22">33211681)</searchLink>
– Name: GrantInfo
  Label: Grant Information
  Group: Grant
  Data: F31 AA029295 United States AA NIAAA NIH HHS
– Name: ChemicalData
  Label: Molecular Sequence
  Group: ChemData
  Data: ClinicalTrials.gov NCT04717544
– Name: NumberCAS
  Label: Substance Nomenclature
  Group: ID
  Data: 6M3C89ZY6R (Nicotine)
– Name: DateEntry
  Label: Entry Date(s)
  Group: Date
  Data: <i>Date Created: </i>20231107 <i>Date Completed: </i>20231108 <i>Latest Revision: </i>20250225
– Name: DateUpdate
  Label: Update Code
  Group: Date
  Data: 20260130
– Name: PubmedCentralID
  Label: PubMed Central ID
  Group: ID
  Data: PMC11849139
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1097/ADM.0000000000001211
– Name: AN
  Label: PMID
  Group: ID
  Data: 37934530
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=37934530
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/ADM.0000000000001211
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 677
    Subjects:
      – SubjectFull: Adult
        Type: general
      – SubjectFull: Humans
        Type: general
      – SubjectFull: Public Health
        Type: general
      – SubjectFull: Nicotine
        Type: general
      – SubjectFull: Tobacco Use
        Type: general
      – SubjectFull: Tobacco Use Disorder
        Type: general
      – SubjectFull: Smoking Cessation
        Type: general
    Titles:
      – TitleFull: Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Meredith LR
      – PersonEntity:
          Name:
            NameFull: Hurley B
      – PersonEntity:
          Name:
            NameFull: Friedman TC
      – PersonEntity:
          Name:
            NameFull: Lee ML
      – PersonEntity:
          Name:
            NameFull: Rodriguez L
      – PersonEntity:
          Name:
            NameFull: Lopez B
      – PersonEntity:
          Name:
            NameFull: Mtume N
      – PersonEntity:
          Name:
            NameFull: Dixon T
      – PersonEntity:
          Name:
            NameFull: Belani HK
      – PersonEntity:
          Name:
            NameFull: Hsieh S
      – PersonEntity:
          Name:
            NameFull: Ray LA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov-Dec 01
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1935-3227
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of addiction medicine
              Type: main
ResultId 1